Tesamorelin 10mg is an investigational research peptide classified as a synthetic analogue of growth hormone–releasing hormone (GHRH). It is studied for its ability to stimulate endogenous growth hormone secretion through interaction with GHRH receptors. Preclinical interest focuses on its role in metabolic regulation, lipolytic pathways, and the modulation of insulin-like growth factor (IGF-1) activity. Tesamorelin continues to be explored for its influence on adipose tissue dynamics and metabolic biomarkers.

Research Applications:

Preclinical and in vitro research has indicated that Tesamorelin may offer potential in the following areas:

Investigating growth hormone release and downstream IGF-1 signalling.

Examining lipolytic pathways and adipose tissue metabolism.

Studying metabolic profiles in models of altered body composition.

Assessing the regulation of hepatic fat and lipid turnover.

Exploring peptide-driven modulation of metabolic and endocrine pathways.

Important Notice:
This product is intended strictly for laboratory research use by qualified professionals. It is not for human or veterinary use, and must not be utilised for therapeutic, diagnostic, or consumable purposes